Aravive Inc
NASDAQ:ARAV
Market Cap (Intraday) | 137.64M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $2.11 |
50-Day MA | $1.89 |
200-Day MA | $1.29 |
Aravive Inc Stock, NASDAQ:ARAV
River Oaks Tower, 3730 Kirby Drive, Houston, Texas 77098
United States of America
Phone: +1.936.355.1910
Number of Employees: 23
Description
Aravive, Inc. operates as a clinical stage biotechnology company, which engages in the development of transformative treatments designed to halt the progression of life threatening disease, including cancer and fibrosis. The company was founded on December 10, 2008 and is headquartered in Houston, TX.